BACKGROUND AND PURPOSE: Our preliminary report on intrathecal urokinase (UK)
infusion into the cisterna magna (CM) with a microcatheter showed good results in terms of …

Background and Purpose—The feasibility of preventing vasospasm by intrathecal
anterograde infusion of urokinase (UK) into the cisterna magna was studied in patients with …

BACKGROUND AND PURPOSE: We developed an experimental canine subarachnoid
hemorrhage (SAH) model in which one-time blood injection by means of a microcatheter …

Background and Purpose—Vasospasm remains the leading cause of death and permanent
neurological disability in patients with aneurysmal subarachnoid hemorrhage (SAH). The …

Background and Purpose—Cisternal irrigation therapy with urokinase (UK) was performed
in multiple institutions to prevent symptomatic vasospasm. The efficacy and safety of this …

Abstract SAFETY AND EFFICACY of the thrombolytic agent urokinase (URO) in the
elimination of subarachnoid clot and prevention of chronic vasospasm was compared with …

BACKROUND AND PURPOSE: Cerebral vasospasm secondary to subarachnoid
hemorrhage (SAH) has been a serious clinical problem. The aim of the present study is to …

✓ The authors have evaluated the efficacy of postoperative intrathecal injections of tissue-
type plasminogen activator (tPA) in preventing cerebral vasospasm in patients with a diffuse …

BACKGROUND: Vasospasm is one of the important factors associated with the functional
prognosis after subarachnoid hemorrhage (SAH). Intracisternal administration of …

Background Double injection of blood into cisterna magna using a rabbit model results in
cerebral vasospasm. An unacceptably high mortality rate tends to limit the application of …